Onukwugha E - Search Results

1

Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel.

Reese ES, Daniel Mullins C, Beitelshees AL, Onukwugha E. Reese ES, et al. Among authors: onukwugha e. Pharmacotherapy. 2012 Apr;32(4):323-32. doi: 10.1002/j.1875-9114.2012.01048. Pharmacotherapy. 2012. PMID: 22461122 Free PMC article.

2

The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model.

Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD. Mitikiri ND, et al. Among authors: onukwugha e. J Comp Eff Res. 2013 Nov;2(6):605-18. doi: 10.2217/cer.13.70. J Comp Eff Res. 2013. PMID: 24236799 Free article.

3

Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients.

Zheng Z, Hanna N, Onukwugha E, Reese ES, Seal B, Mullins CD. Zheng Z, et al. Among authors: onukwugha e. Cancer Med. 2014 Feb;3(1):124-33. doi: 10.1002/cam4.176. Epub 2014 Jan 7. Cancer Med. 2014. PMID: 24403130 Free PMC article.

4

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients.

Reese ES, Onukwugha E, Hanna N, Seal BS, Mullins CD. Reese ES, et al. Among authors: onukwugha e. Cancer Med. 2013 Dec;2(6):907-15. doi: 10.1002/cam4.143. Epub 2013 Oct 10. Cancer Med. 2013. PMID: 24403264 Free PMC article.

5

Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk.

Onwudiwe NC, Kwok Y, Onukwugha E, Sorkin JD, Zuckerman IH, Shaya FT, Daniel Mullins C. Onwudiwe NC, et al. Among authors: onukwugha e. Cancer Med. 2014 Oct;3(5):1342-52. doi: 10.1002/cam4.283. Epub 2014 Jul 10. Cancer Med. 2014. PMID: 25044867 Free PMC article.

6

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.

Hussain A, Aly A, Daniel Mullins C, Qian Y, Arellano J, Onukwugha E. Hussain A, et al. Among authors: onukwugha e. Cancer Med. 2016 Nov;5(11):3300-3309. doi: 10.1002/cam4.914. Epub 2016 Oct 11. Cancer Med. 2016. PMID: 27730756 Free PMC article.

7

Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.

Grabner M, Onukwugha E, Jain R, Mullins CD. Grabner M, et al. Among authors: onukwugha e. Am J Manag Care. 2011 May 1;17(5 Spec No):e151-9. Am J Manag Care. 2011. PMID: 21711065 Free article.

8

Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.

Grabner M, Onukwugha E, Jain R, Mullins CD. Grabner M, et al. Among authors: onukwugha e. J Oncol Pract. 2011 May;7(3 Suppl):e16s-24s. doi: 10.1200/JOP.2011.000294. J Oncol Pract. 2011. PMID: 21886506 Free PMC article.

9

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.

Mullins CD, Hsiao FY, Onukwugha E, Pandya NB, Hanna N. Mullins CD, et al. Among authors: onukwugha e. Cancer. 2012 Jun 15;118(12):3173-81. doi: 10.1002/cncr.26613. Epub 2011 Oct 21. Cancer. 2012. PMID: 22020739 Free article.

10

Cost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patients.

Zheng Z, Onukwugha E, Hanna N, Bikov K, Seal B, Mullins CD. Zheng Z, et al. Among authors: onukwugha e. Adv Ther. 2014 Jul;31(7):724-34. doi: 10.1007/s12325-014-0134-8. Epub 2014 Jul 15. Adv Ther. 2014. PMID: 25022528 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters